ICICI Prudential Nifty Pharma Index Fund Regular Growth

• Alpha 0.00%
• Beta 0.00
• Sharpe Ratio0.00
• Std Deviation 0.00%
• Tracking Error 0.00%

The objective of the Scheme is to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index. However, there is no assurance or guarantee that the investment objective of the scheme shall be achieved.

The ICICI Prudential Nifty Pharma Index Fund Regular Growth has an AUM of 88.06 crores & has delivered CAGR of 0.00% in the last 5 years. The fund has an exit load of 0.00% and an expense ratio of 0.98%. The minimum investment in ICICI Prudential Nifty Pharma Index Fund Regular Growth is Rs 1000 and the minimum SIP is Rs 1000.

As per morningstar the risk & return rating of the fund are Medium & - respectively.

The top holdings of the fund include Sun Pharmaceutical Industries, Cipla, Dr Reddy's Laboratories & Divi's Laboratories.

The major sectors where the fund is invested are Biotechnology & Drugs & Major Drugs.

Some of the similar funds are LIC MF BSE Sensex Index Growth, Tata Nifty Auto Index Fund Regular Growth, ICICI Prudential Nifty Pharma Index Fund Regular Growth, Tata Nifty Financial Services Index Fund Regular Growth, Axis Nifty500 Quality 50 Index Fund Regular Growth. ICICI Prudential Nifty Pharma Index Fund Regular Growth has a sharpe ratio of 0.00 & a standard deviation of 0.00%.